کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4000023 1259365 2013 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Defining prostate cancer risk before prostate biopsy
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی تومور شناسی
پیش نمایش صفحه اول مقاله
Defining prostate cancer risk before prostate biopsy
چکیده انگلیسی

Prostate cancer is the most commonly diagnosed cancer in men. At present, patients are selected for prostate biopsy on the basis of age, serum prostate specific antigen (PSA), and prostatic digital rectal examination (DRE) findings. However, due to limitations in the use of PSA and DRE, many patients undergo unnecessary prostate biopsy. A further problem arises as many patients are diagnosed and treated for indolent disease. This review of the literature highlights the strengths and weaknesses of existing methods of prebiopsy risk stratification and evaluates promising serum, urine, and radiologic prostate cancer biomarkers, which may improve risk stratification for prostate biopsy in the future.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Urologic Oncology: Seminars and Original Investigations - Volume 31, Issue 8, November 2013, Pages 1408–1418
نویسندگان
, , , ,